MENU

Wattle Health Australia Ltd (ASX:WHA) shares are down 33% in a month

It has been another disappointing day of trade for the Wattle Health Australia Ltd (ASX: WHA) share price.

Despite the release of yet another announcement, the baby food and infant formula company’s shares are down over 5% to $1.10 in afternoon trade.

This means they have lost over a third of their value since this time last month.

What was today’s announcement?

This afternoon Wattle Health announced that it has signed an agreement with Quality Brands International Direct (QBID) that will provide it with access to major export markets via e-commerce platforms.

According to the release, management believes this is an important and strategic milestone which will allow the company to “take advantage of the lucrative e-commerce market” and further strengthen its “strong retail distribution strategy within those markets.”

What is QBID?

The release explains that QBID is a Melbourne based company providing access to major export markets via an e-commerce model.

Its main focus is the China market where it represents more than 20 brands and operates dedicated brand stores on major e-commerce platforms including TMall, Kaola, and JD.com.

It also builds brand support through popular Chinese social media platforms including WeChat and Weibo.

Should you invest?

I’m relieved to see that the market has not reacted to this announcement.

In my opinion it was unnecessary and seems overly promotional. Which history has taught us to be very cautious with.

In light of this, I would suggest investors stay well clear of Wattle Health until it is generating meaningful revenues and letting the numbers do the talking.

Until then, I would focus on infant formula shares that are delivering results such as A2 Milk Company Ltd (ASX: A2M) and Bellamy’s Australia Ltd (ASX: BAL). Especially after recent share price weakness means they are trading at fairer prices today.

Did you miss the infant formula boom? Then don't miss out on this next boom.

7 of 8 People Are Clueless About This Trillion-Dollar Market

One of our investors has recently returned from a research trip to Silicon Valley... and has a warning for fellow investors:

Because he works for an organization dedicated to spreading great investing ideas, his video report is free today... so you can see it and decide for yourself.

Don't miss your chance click here to learn about this warning and how you might be able to profit!

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.